Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Collegium Pharmaceutical stock

Learn how to easily invest in Collegium Pharmaceutical stock.

Collegium Pharmaceutical Inc is a drug manufacturers-specialty & generic business based in the US. Collegium Pharmaceutical shares (COLL) are listed on the NASDAQ and all prices are listed in US Dollars. Collegium Pharmaceutical employs 152 staff and has a trailing 12-month revenue of around $313.5 million.

How to buy shares in Collegium Pharmaceutical

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – COLL – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Collegium Pharmaceutical stock price (NASDAQ: COLL)

Use our graph to track the performance of COLL stocks over time.

Collegium Pharmaceutical shares at a glance

Information last updated 2022-09-19.
Latest market close$16.05
52-week range$14.04 - $22.89
50-day moving average $17.82
200-day moving average $17.94
Wall St. target price$32.80
PE ratio 15.3514
Dividend yield $0 (0%)
Earnings per share (TTM) $1.11

Buy Collegium Pharmaceutical shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 8 of 8
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$100
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Collegium Pharmaceutical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Collegium Pharmaceutical price performance over time

Historical closes compared with the close of $16.05 from 2022-09-23

1 week (2022-09-20) -7.23%
1 month (2022-08-26) -9.17%
3 months (2022-06-27) -14.54%
6 months (2022-03-23) N/A
1 year (2021-09-27) -22.58%
2 years (2020-09-25) -13.20%
3 years (2019-09-27) 40.17%
5 years (2017-09-27) 51.56%

Is Collegium Pharmaceutical stock undervalued or overvalued?

Valuing Collegium Pharmaceutical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Collegium Pharmaceutical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Collegium Pharmaceutical's P/E ratio

Collegium Pharmaceutical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 15x. In other words, Collegium Pharmaceutical shares trade at around 15x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Collegium Pharmaceutical's EBITDA

Collegium Pharmaceutical's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $110.9 million.

The EBITDA is a measure of a Collegium Pharmaceutical's overall financial performance and is widely used to measure a its profitability.

Collegium Pharmaceutical financials

Revenue TTM $313.5 million
Operating margin TTM 5.94%
Gross profit TTM $217.8 million
Return on assets TTM 1.19%
Return on equity TTM -15.64%
Profit margin -11.24%
Book value $5.79
Market capitalisation $581.5 million

TTM: trailing 12 months

Collegium Pharmaceutical share dividends

We're not expecting Collegium Pharmaceutical to pay a dividend over the next 12 months.

Collegium Pharmaceutical share price volatility

Over the last 12 months, Collegium Pharmaceutical's shares have ranged in value from as little as $14.04 up to $22.888. A popular way to gauge a stock's volatility is its "beta".

COLL.US volatility(beta: 0.85)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Collegium Pharmaceutical's is 0.849. This would suggest that Collegium Pharmaceutical's shares are less volatile than average (for this exchange).

Collegium Pharmaceutical overview

Collegium Pharmaceutical, Inc. , a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc.

Frequently asked questions

What percentage of Collegium Pharmaceutical is owned by insiders or institutions?
Currently 1.337% of Collegium Pharmaceutical shares are held by insiders and 111.045% by institutions.
How many people work for Collegium Pharmaceutical?
Latest data suggests 152 work at Collegium Pharmaceutical.
When does the fiscal year end for Collegium Pharmaceutical?
Collegium Pharmaceutical's fiscal year ends in December.
Where is Collegium Pharmaceutical based?
Collegium Pharmaceutical's address is: 100 Technology Center Drive, Stoughton, MA, United States, 02072
What is Collegium Pharmaceutical's ISIN number?
Collegium Pharmaceutical's international securities identification number is: US19459J1043
What is Collegium Pharmaceutical's CUSIP number?
Collegium Pharmaceutical's Committee on Uniform Securities Identification Procedures number is: 19459J104

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site